Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1977 1
1978 1
1979 4
1980 1
1983 1
1987 1
1988 1
1989 1
1990 6
1991 2
1992 10
1993 6
1994 7
1995 2
1996 6
1997 8
1998 4
1999 2
2000 10
2001 1
2002 5
2003 3
2004 4
2005 3
2006 3
2007 2
2008 2
2009 4
2011 3
2012 3
2013 4
2014 4
2015 8
2016 5
2017 2
2018 3
2019 4
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 11061760

138 results
Results by year
Filters applied: . Clear all
Page 1
Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Members of the Collaborative European Multicenter Study Group.
Herting E, Gefeller O, Land M, van Sonderen L, Harms K, Robertson B. Herting E, et al. Pediatrics. 2000 Nov;106(5):957-64; discussion 1135. doi: 10.1542/peds.106.5.957. Pediatrics. 2000. PMID: 11061760 Clinical Trial.
Effectiveness of treatment with surfactant in premature infants with respiratory failure and pulmonary infection.
Vento G, Tana M, Tirone C, Aurilia C, Lio A, Perelli S, Ricci C, Romagnoli C. Vento G, et al. Acta Biomed. 2012;83 Suppl 1:33-6. Acta Biomed. 2012. PMID: 23029875
A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
Hudak ML, Martin DJ, Egan EA, Matteson EJ, Cummings NJ, Jung AL, Kimberlin LV, Auten RL, Rosenberg AA, Asselin JM, Belcastro MR, Donohue PK, Hamm CR Jr, Jansen RD, Brody AS, Riddlesberger MM, Montgomery P. Hudak ML, et al. Pediatrics. 1997 Jul;100(1):39-50. doi: 10.1542/peds.100.1.39. Pediatrics. 1997. PMID: 9200358 Clinical Trial.
Comparison of Infasurf (calf lung surfactant extract) to Survanta (Beractant) in the treatment and prevention of respiratory distress syndrome.
Bloom BT, Kattwinkel J, Hall RT, Delmore PM, Egan EA, Trout JR, Malloy MH, Brown DR, Holzman IR, Coghill CH, Carlo WA, Pramanik AK, McCaffree MA, Toubas PL, Laudert S, Gratny LL, Weatherstone KB, Seguin JH, Willett LD, Gutcher GR, Mueller DH, Topper WH. Bloom BT, et al. Pediatrics. 1997 Jul;100(1):31-8. doi: 10.1542/peds.100.1.31. Pediatrics. 1997. PMID: 9200357 Clinical Trial.
Early versus late surfactant treatment in preterm infants of 27 to 32 weeks' gestational age: a multicenter controlled clinical trial.
Gortner L, Wauer RR, Hammer H, Stock GJ, Heitmann F, Reiter HL, Kühl PG, Möller JC, Friedrich HJ, Reiss I, Hentschel R, Jorch G, Hieronimi G, Kuhls E. Gortner L, et al. Pediatrics. 1998 Nov;102(5):1153-60. doi: 10.1542/peds.102.5.1153. Pediatrics. 1998. PMID: 9794948 Clinical Trial.
Natural surfactant for neonatal respiratory distress syndrome in very premature infants: a 1992 update.
Gortner L. Gortner L. J Perinat Med. 1992;20(6):409-19. doi: 10.1515/jpme.1992.20.6.409. J Perinat Med. 1992. PMID: 1293266 Review.
Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
Stevens TP, Blennow M, Soll RF. Stevens TP, et al. Cochrane Database Syst Rev. 2002;(2):CD003063. doi: 10.1002/14651858.CD003063. Cochrane Database Syst Rev. 2002. PMID: 12076469 Review.
A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
Sinha SK, Lacaze-Masmonteil T, Valls i Soler A, Wiswell TE, Gadzinowski J, Hajdu J, Bernstein G, Sanchez-Luna M, Segal R, Schaber CJ, Massaro J, d'Agostino R; Surfaxin Therapy Against Respiratory Distress Syndrome Collaborative Group. Sinha SK, et al. Pediatrics. 2005 Apr;115(4):1030-8. doi: 10.1542/peds.2004-2231. Pediatrics. 2005. PMID: 15805381 Clinical Trial.
138 results
Jump to page
Feedback